About Shibuya Kogyo
Shibuya Kogyo is a company based in Kanazawa (Japan) founded in 1931.. Shibuya Kogyo operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Kanazawa, Japan
- Stage Public
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
- Legal Name Shibuya Corporation
-
Annual Revenue
$893.85 M (USD)11.77as on Jun 30, 2025
-
Net Profit
$69.63 M (USD)2.78as on Jun 30, 2025
-
EBITDA
$116.04 M (USD)2.84as on Jun 30, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Shibuya Kogyo
Shibuya Kogyo is a publicly listed company on the TSE with ticker symbol 6340 in Japan, operating in the Producer manufacturing sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Shibuya Kogyo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Shibuya Kogyo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Shibuya Kogyo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Shibuya Kogyo Comparisons
Competitors of Shibuya Kogyo
Shibuya Kogyo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Shibuya Kogyo
Frequently Asked Questions about Shibuya Kogyo
When was Shibuya Kogyo founded?
Shibuya Kogyo was founded in 1931.
Where is Shibuya Kogyo located?
Shibuya Kogyo is headquartered in Kanazawa, Japan. It is registered at Kanazawa, Ishikawa, Japan.
What is the annual revenue of Shibuya Kogyo?
Annual revenue of Shibuya Kogyo is $893.85M as on Jun 30, 2025.
What does Shibuya Kogyo do?
Founded in 1931 and headquartered in Kanazawa, Japan, Shibuya Kogyo operates as a manufacturer of medical devices within the Shibuya Group. Systems for medical equipment, cleaning, pharmaceutical and regenerative medicine manufacturing, and robotics are provided through its subsidiaries. Collaboration with Cyfuse Biomedical resulted in the Regenova 3D printer, which constructs artificial human tissue from cell aggregates for applications in drug testing, cosmetics, and potential organ transplants to reduce rejection risks.
Who are the top competitors of Shibuya Kogyo?
Shibuya Kogyo's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Is Shibuya Kogyo publicly traded?
Yes, Shibuya Kogyo is publicly traded on TSE under the ticker symbol 6340.
What is Shibuya Kogyo's ticker symbol?
The ticker symbol of Shibuya Kogyo is 6340 on TSE.